ETON PHARMACEUTICALS INC. - COMMON STOCK
16,42
14-февраля-25 16:45:00
15 мин. задержка
Акции
-0,40
-2,35%
Сегодняшний диапазон
15,91 - 16,91
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
03 авг 2021 16:05:02 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
15 июн 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15 июн 2021 10:37:52 Источник Nasdaq GlobeNewswire
-
28 май 2021 08:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Record Revenue and Earnings
13 май 2021 16:05:01 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04 май 2021 16:05:01 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17 мар 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16 мар 2021 16:02:00 Источник Nasdaq GlobeNewswire
-
04 мар 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16 фев 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08 фев 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 янв 2021 08:00:01 Источник Nasdaq GlobeNewswire